ZENITH DRUGS LIMITED Share Price

Zenith Drugs Ltd is an India-based pharmaceutical company. The Company is mainly engaged in the business of manufacturing and trading of medicine. The Company offers a range of formulations in various forms, such as ORS powder, liquid oral, ointments, creams, gels and liquid externals, capsules, tablets. Its liquid oral products include Aceclofenac & Paracetamol Suspension; Albendazole Oral Suspension BP 25 mg/ml; Ambroxol Hydrochloride & Levocetirizine Dihydrochloride Syrup; Bromhexine Hydrochloride Syrup 4mg/5ml; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Chlorphenamine, Ammonium Chloride and Sodium Citrate Syrup; Chlorpheniramine Maleate Oral Solution USP 2 mg / 5 ml, and others. Its ointment products include Cetrimide Cream BP 0.5% w/w, Chloroxylenol Cream 0.8% w/w, Ciprofloxacin Cream 0.5% w/w, Ciprofloxacin with Fluocinolone & Clotrimazole Cream and others. As of 15 Jun 2026, ZENITH DRUGS LIMITED share price is ₹43.90. The stock opened at ₹43.75, compared to its previous close of ₹41.20. During today's trading session, ZENITH DRUGS LIMITED share price moved in the range of ₹43.75 to ₹44.00, with an average price of ₹43.88 for the day. Looking at its last 52-week, the stock has touched a low of ₹43.75 and a high of ₹44.00. On the performance front, ZENITH DRUGS LIMITED share price has declined by 17.17% over the last six months and is down 35.82% on a year-on-year basis.

The market capitalization of ZENITH DRUGS LIMITED is ₹108 Crs, with a P/E ratio of 11.2 and a dividend yield of 0.00%.